Skip to main content
Report this ad

Johnson & Johnson partners with JDRF to develop Artificial Pancreas

January 2010, the Juvenile Diabetes Research Foundation (JDRF) announced a partnership with Animas Corporation (a Johnson & Johnson company) to develop an "articifial pancreas."  The partnership plans to develop an automated system to manage type 1 diabetes, conduct extensive clinical trails for safety, and submit the system to the U.S. Food and Drug Administration (FDA) for approval.

JDRF will fund over $8 million over the next three years, working toward introducing a first-generation automated system within four years.  The system will be partially automated, wirelessly connecting an insulin pump to a continuous glucose monitor.  The first-generation system will still require the user to manually instruct some insulin delivery, but will be a great step forward in the ease of diabetes management.

JDRF is the leading charitable funder of type 1 diabetes research.  Local donations can be made to the JDRF Rocky Mountain Chapter at 8055 East Tufts Avenue, Suite 770, Denver, CO  80237.


Report this ad